Isabel Machuca

2.6k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Isabel Machuca is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, Isabel Machuca has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Molecular Medicine and 17 papers in Epidemiology. Recurrent topics in Isabel Machuca's work include Antibiotic Resistance in Bacteria (18 papers), Antibiotic Use and Resistance (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Isabel Machuca is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antibiotic Use and Resistance (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Isabel Machuca collaborates with scholars based in Spain, United States and Italy. Isabel Machuca's co-authors include Belén Gutiérrez‐Gutiérrez, Jesús Rodríguez‐Baño, Álvaro Pascual, Antonio Rivero, Julián Torre‐Cisneros, Elena Pérez‐Nadales, Irene Gracia-Ahufinger, Ángela Cano, Antonio Rivero‐Juárez and Luis Martínez‐Martínez and has published in prestigious journals such as PLoS ONE, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

Isabel Machuca

41 papers receiving 1.2k citations

Hit Papers

Treatment of Infections Caused by Extended-Spectrum-Beta-... 2018 2026 2020 2023 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
    2018 513 citations Jesús Rodríguez‐Baño, Belén Gutiérrez‐Gutiérrez et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Machuca Spain 17 750 342 320 297 255 43 1.2k
Εlias Iosifidis Greece 23 792 1.1× 459 1.3× 670 2.1× 302 1.0× 382 1.5× 82 1.5k
Fabio Grill Spain 9 773 1.0× 204 0.6× 533 1.7× 270 0.9× 79 0.3× 12 995
Nenad Maćešić Australia 17 577 0.8× 248 0.7× 275 0.9× 131 0.4× 205 0.8× 41 1.0k
Iciar Rodríguez-Avial Spain 23 580 0.8× 347 1.0× 469 1.5× 142 0.5× 435 1.7× 66 1.4k
Ki-Deok Lee South Korea 10 582 0.8× 198 0.6× 418 1.3× 423 1.4× 162 0.6× 17 1.1k
Seong Yeol Ryu South Korea 24 541 0.7× 137 0.4× 677 2.1× 191 0.6× 464 1.8× 78 1.5k
Jun Seong Son South Korea 18 407 0.5× 115 0.3× 476 1.5× 128 0.4× 385 1.5× 46 1.0k
Francisco Gudiol Spain 13 321 0.4× 236 0.7× 683 2.1× 179 0.6× 240 0.9× 23 1.2k
A. Péchinot France 17 378 0.5× 206 0.6× 319 1.0× 66 0.2× 197 0.8× 61 1.0k
Georgios Daikos Greece 15 338 0.5× 120 0.4× 311 1.0× 156 0.5× 301 1.2× 32 928

Countries citing papers authored by Isabel Machuca

Since Specialization
Citations

This map shows the geographic impact of Isabel Machuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Machuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Machuca more than expected).

Fields of papers citing papers by Isabel Machuca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Machuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Machuca. The network helps show where Isabel Machuca may publish in the future.

Co-authorship network of co-authors of Isabel Machuca

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Machuca. A scholar is included among the top collaborators of Isabel Machuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Machuca. Isabel Machuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Machuca, Isabel, Irene Gracia-Ahufinger, Rafael Ruiz-Montero, et al.. (2024). Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital. Antibiotics. 13(9). 792–792. 1 indexed citations
3.
Machuca, Isabel, Irene Gracia-Ahufinger, Rosa Girón, et al.. (2024). Real-World Experience of Imipenem–Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study). Infectious Diseases and Therapy. 14(1). 283–292. 6 indexed citations
4.
Merino, N., Isabel Machuca, Julia Guzmán-Puche, et al.. (2023). Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. International Journal of Antimicrobial Agents. 62(1). 106818–106818. 9 indexed citations
5.
Brañas, Fátima, Miguel Torralba, Antonio Antela, et al.. (2023). Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV. BMC Geriatrics. 23(1). 4–4. 19 indexed citations
6.
Pintado, Vicente, Patricia Ruíz-Garbajosa, David Aguilera‐Alonso, et al.. (2022). Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(6). 360–370. 16 indexed citations
7.
Machuca, Isabel, Julia Guzmán-Puche, Elena Pérez‐Nadales, et al.. (2022). Community-acquired bacteraemia by Klebsiella pneumoniae producing KPC-3 and resistant to ceftazidime/avibactam. Journal of Global Antimicrobial Resistance. 30. 399–402. 4 indexed citations
8.
Frías, Mario, Jose M. Moyano, Antonio Rivero‐Juárez, et al.. (2020). Classification Accuracy of Hepatitis C Virus Infection Outcome: Data Mining Approach. Journal of Medical Internet Research. 23(2). e18766–e18766. 3 indexed citations
9.
Machuca, Isabel, Belén Gutiérrez‐Gutiérrez, Ángela Cano, et al.. (2019). External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance. International Journal of Antimicrobial Agents. 54(4). 442–448. 14 indexed citations
10.
Rodríguez-Gómez, Jorge, Elena Pérez‐Nadales, Belén Gutiérrez‐Gutiérrez, et al.. (2019). Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment. Journal of Infection. 79(3). 245–252. 14 indexed citations
11.
Rodríguez‐Baño, Jesús, Belén Gutiérrez‐Gutiérrez, Isabel Machuca, & Álvaro Pascual. (2018). Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clinical Microbiology Reviews. 31(2). 513 indexed citations breakdown →
12.
López‐López, Pedro, María Á. Risalde, Mario Frías, et al.. (2018). Risk factors associated with hepatitis E virus in pigs from different production systems. Veterinary Microbiology. 224. 88–92. 34 indexed citations
13.
Machuca, Isabel, Irene Gracia-Ahufinger, Elena Pérez‐Nadales, et al.. (2017). The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii. Clinical Microbiology and Infection. 24(6). 630–634. 39 indexed citations
14.
Rivero‐Juárez, Antonio, Mario Frías, Pedro López‐López, et al.. (2017). Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?. Clinical Infectious Diseases. 64(7). 964–966. 11 indexed citations
15.
Risalde, María Á., Antonio Rivero‐Juárez, Mario Frías, et al.. (2017). Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar. PLoS ONE. 12(11). e0186858–e0186858. 25 indexed citations
16.
Machuca, Isabel, Sara Cantisán, C. Natera, et al.. (2016). Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study. Journal of Antimicrobial Chemotherapy. 71(9). 2606–2611. 8 indexed citations
17.
Machuca, Isabel, Belén Gutiérrez‐Gutiérrez, Irene Gracia-Ahufinger, et al.. (2016). Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 71(11). 3242–3249. 36 indexed citations
18.
Bañón, Sara, Isabel Machuca, Ana Moreno, et al.. (2014). Efficacy, safety, and lack of interactions with the use of raltegravir in HIV‐infected patients undergoing antineoplastic chemotherapy. Journal of the International AIDS Society. 17(4S3). 19590–19590. 5 indexed citations
19.
Bañón, Sara, et al.. (2014). Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs. European Journal of Endocrinology. 171(5). 545–554. 42 indexed citations
20.
Fuentes‐Arderiu, Xavier, Pedro Alía, & Isabel Machuca. (1994). Analytical goals for rectilinear calibration functions. Clinica Chimica Acta. 224(2). 119–123. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Εlias Iosifidis Breakdown of academic impact, for papers by Fabio Grill Breakdown of academic impact, for papers by Nenad Maćešić Breakdown of academic impact, for papers by Iciar Rodríguez-Avial Breakdown of academic impact, for papers by Ki-Deok Lee Breakdown of academic impact, for papers by Seong Yeol Ryu Breakdown of academic impact, for papers by Jun Seong Son Breakdown of academic impact, for papers by Francisco Gudiol Breakdown of academic impact, for papers by A. Péchinot Breakdown of academic impact, for papers by Georgios Daikos
Rankless by CCL
2026